McDermott Will & Schulte authored an article for PLANSPONSOR examining how employers and plan sponsors should cover GLP-1 medications, including FDA-approved uses, off-label prescribing, and compliance risks under the ACA.

Public source

Publisher name

Public post

GLP-1 medications are dominating headlines, and employers are under real pressure to define their coverage strategy. In an article we authored for PLANSPONSOR, my McDerm…

Log in to read the full post

Company

McDermott Will & Schulte

Industry
Law Practice
Location
20+ Locations, US
Company size
1,001–5,000 employees

About McDermott Will & Schulte

McDermott Will & Emery is now McDermott Will & Schulte. Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better. Attorney Advertising. Prior results do not guarantee a similar outcome.

See more

Latest activity

39 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.